CN109420078A - A kind of Chinese medicinal formulae for the conditioning of intermingled phlegm and blood stasis type Stein-Leventhal syndrome - Google Patents
A kind of Chinese medicinal formulae for the conditioning of intermingled phlegm and blood stasis type Stein-Leventhal syndrome Download PDFInfo
- Publication number
- CN109420078A CN109420078A CN201810968222.0A CN201810968222A CN109420078A CN 109420078 A CN109420078 A CN 109420078A CN 201810968222 A CN201810968222 A CN 201810968222A CN 109420078 A CN109420078 A CN 109420078A
- Authority
- CN
- China
- Prior art keywords
- parts
- blood stasis
- phlegm
- semen coicis
- conditioning
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010062717 Increased upper airway secretion Diseases 0.000 title claims abstract description 39
- 208000026435 phlegm Diseases 0.000 title claims abstract description 39
- 239000008280 blood Substances 0.000 title claims abstract description 34
- 201000010065 polycystic ovary syndrome Diseases 0.000 title claims abstract description 34
- 210000004369 blood Anatomy 0.000 title claims abstract description 33
- 206010036049 Polycystic ovaries Diseases 0.000 title claims abstract description 23
- 230000003750 conditioning effect Effects 0.000 title claims abstract description 20
- 210000000582 semen Anatomy 0.000 claims abstract description 34
- 239000003814 drug Substances 0.000 claims abstract description 32
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 20
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 20
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 19
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 19
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 19
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 19
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 18
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 18
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 18
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 18
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 18
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 18
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 18
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 18
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 18
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 18
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims abstract description 18
- 210000003038 endothelium Anatomy 0.000 claims abstract description 17
- 229940079593 drug Drugs 0.000 claims abstract description 11
- 235000013305 food Nutrition 0.000 claims abstract description 11
- 244000088415 Raphanus sativus Species 0.000 claims abstract description 5
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 4
- 239000000203 mixture Substances 0.000 claims abstract 2
- 241000736199 Paeonia Species 0.000 claims description 16
- 229940126680 traditional chinese medicines Drugs 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 22
- 210000000952 spleen Anatomy 0.000 abstract description 12
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 239000000796 flavoring agent Substances 0.000 abstract description 7
- 235000019634 flavors Nutrition 0.000 abstract description 7
- 208000024891 symptom Diseases 0.000 abstract description 6
- 238000005728 strengthening Methods 0.000 abstract description 4
- 244000170916 Paeonia officinalis Species 0.000 abstract description 3
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 abstract description 3
- 229940126678 chinese medicines Drugs 0.000 abstract description 2
- 235000013350 formula milk Nutrition 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 241001092040 Crataegus Species 0.000 description 14
- 241000220259 Raphanus Species 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 9
- 206010001928 Amenorrhoea Diseases 0.000 description 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 206010036790 Productive cough Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000001672 ovary Anatomy 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 239000000341 volatile oil Substances 0.000 description 7
- 206010000060 Abdominal distension Diseases 0.000 description 6
- 206010041349 Somnolence Diseases 0.000 description 6
- 230000013872 defecation Effects 0.000 description 6
- 210000003414 extremity Anatomy 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 230000005906 menstruation Effects 0.000 description 6
- 208000002874 Acne Vulgaris Diseases 0.000 description 5
- 208000032841 Bulimia Diseases 0.000 description 5
- 206010006550 Bulimia nervosa Diseases 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 208000035175 Oligomenorrhea Diseases 0.000 description 5
- 206010030295 Oligomenorrhoea Diseases 0.000 description 5
- 206010000496 acne Diseases 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 229940088597 hormone Drugs 0.000 description 5
- 239000005556 hormone Substances 0.000 description 5
- 201000010066 hyperandrogenism Diseases 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 206010022489 Insulin Resistance Diseases 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 208000021267 infertility disease Diseases 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- -1 linoleic acid Ester Chemical class 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 4
- 244000077995 Coix lacryma jobi Species 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 3
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 150000002213 flavones Chemical class 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 229930182478 glucoside Natural products 0.000 description 3
- 150000008131 glucosides Chemical class 0.000 description 3
- 208000000509 infertility Diseases 0.000 description 3
- 230000036512 infertility Effects 0.000 description 3
- 231100000535 infertility Toxicity 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- WUYQEGNOQLRQAQ-CQSZACIVSA-N (+)-pronuciferine Chemical compound C([C@H]1N(C)CCC=2C=C(C(=C3C=21)OC)OC)C13C=CC(=O)C=C1 WUYQEGNOQLRQAQ-CQSZACIVSA-N 0.000 description 2
- JZQKTMZYLHNFPL-BLHCBFLLSA-N (2E,4E)-deca-2,4-dienal Chemical compound CCCCC\C=C\C=C\C=O JZQKTMZYLHNFPL-BLHCBFLLSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- LVBXEMGDVWVTGY-VOTSOKGWSA-N (E)-oct-2-enal Chemical compound CCCCC\C=C\C=O LVBXEMGDVWVTGY-VOTSOKGWSA-N 0.000 description 2
- MOQGCGNUWBPGTQ-UHFFFAOYSA-N 2,6,6-trimethyl-1-cyclohexene-1-carboxaldehyde Chemical compound CC1=C(C=O)C(C)(C)CCC1 MOQGCGNUWBPGTQ-UHFFFAOYSA-N 0.000 description 2
- ZXJJBDHPUHUUHD-UHFFFAOYSA-N 4',5,7-Trimethoxyflavone Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(OC)C=C(OC)C=C2O1 ZXJJBDHPUHUUHD-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000276331 Citrus maxima Species 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 241000657480 Crataegus pinnatifida Species 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- NIQCNGHVCWTJSM-UHFFFAOYSA-N Dimethyl phthalate Chemical compound COC(=O)C1=CC=CC=C1C(=O)OC NIQCNGHVCWTJSM-UHFFFAOYSA-N 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 208000008899 Habitual abortion Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 2
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical group SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 239000003098 androgen Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229960004106 citric acid Drugs 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 150000002085 enols Chemical class 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 230000035558 fertility Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical group CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- IGGUPRCHHJZPBS-UHFFFAOYSA-N nonacosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCC IGGUPRCHHJZPBS-UHFFFAOYSA-N 0.000 description 2
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 2
- 210000002394 ovarian follicle Anatomy 0.000 description 2
- IJTNSXPMYKJZPR-UHFFFAOYSA-N parinaric acid Chemical compound CCC=CC=CC=CC=CCCCCCCCC(O)=O IJTNSXPMYKJZPR-UHFFFAOYSA-N 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- YCOZIPAWZNQLMR-UHFFFAOYSA-N pentadecane Chemical compound CCCCCCCCCCCCCCC YCOZIPAWZNQLMR-UHFFFAOYSA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000001161 piper cubeba l. fruit oil Substances 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- HDDLVZWGOPWKFW-UHFFFAOYSA-N trimethyl 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound COC(=O)CC(O)(C(=O)OC)CC(=O)OC HDDLVZWGOPWKFW-UHFFFAOYSA-N 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- WUYQEGNOQLRQAQ-UHFFFAOYSA-N (+)-pronuciferine Natural products C1=2C3=C(OC)C(OC)=CC=2CCN(C)C1CC13C=CC(=O)C=C1 WUYQEGNOQLRQAQ-UHFFFAOYSA-N 0.000 description 1
- VSMOENVRRABVKN-UHFFFAOYSA-N (+/-)-matsutakeol Natural products CCCCCC(O)C=C VSMOENVRRABVKN-UHFFFAOYSA-N 0.000 description 1
- VZTUKBKUWSHDFM-CYBMUJFWSA-N (-)-annonaine Chemical compound C1C2=CC=CC=C2C2=C(OCO3)C3=CC3=C2[C@@H]1NCC3 VZTUKBKUWSHDFM-CYBMUJFWSA-N 0.000 description 1
- FFDULTAFAQRACT-NYYYOYJKSA-N (-)-syringaresinol O,O'-bis(beta-D-glucoside) Chemical compound COC1=CC([C@H]2[C@H]3[C@H]([C@@H](OC3)C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=C(OC)C=3)CO2)=CC(OC)=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FFDULTAFAQRACT-NYYYOYJKSA-N 0.000 description 1
- OSELKOCHBMDKEJ-UHFFFAOYSA-N (10R)-3c-Hydroxy-10r.13c-dimethyl-17c-((R)-1-methyl-4-isopropyl-hexen-(4c)-yl)-(8cH.9tH.14tH)-Delta5-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=CC)C(C)C)C1(C)CC2 OSELKOCHBMDKEJ-UHFFFAOYSA-N 0.000 description 1
- SATICYYAWWYRAM-UHFFFAOYSA-N (2E,4E)-2,4-heptadienal Natural products CCC=CC=CC=O SATICYYAWWYRAM-UHFFFAOYSA-N 0.000 description 1
- HZYHMHHBBBSGHB-ODYTWBPASA-N (2E,6Z)-nona-2,6-dienal Chemical compound CC\C=C/CC\C=C\C=O HZYHMHHBBBSGHB-ODYTWBPASA-N 0.000 description 1
- NLAWPKPYBMEWIR-SKYQDXIQSA-N (2S)-poncirin Chemical compound C1=CC(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)=CC(O)=C2C(=O)C1 NLAWPKPYBMEWIR-SKYQDXIQSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- CUXYLFPMQMFGPL-UHFFFAOYSA-N (9Z,11E,13E)-9,11,13-Octadecatrienoic acid Natural products CCCCC=CC=CC=CCCCCCCCC(O)=O CUXYLFPMQMFGPL-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- ZCHHRLHTBGRGOT-SNAWJCMRSA-N (E)-hex-2-en-1-ol Chemical compound CCC\C=C\CO ZCHHRLHTBGRGOT-SNAWJCMRSA-N 0.000 description 1
- SATICYYAWWYRAM-VNKDHWASSA-N (E,E)-hepta-2,4-dienal Chemical compound CC\C=C\C=C\C=O SATICYYAWWYRAM-VNKDHWASSA-N 0.000 description 1
- BOKVLBSSPUTWLV-MRXNPFEDSA-N (R)-N-methylcoclaurine Chemical compound C([C@H]1N(C)CCC=2C=C(C(=CC=21)O)OC)C1=CC=C(O)C=C1 BOKVLBSSPUTWLV-MRXNPFEDSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- QOPYYRPCXHTOQZ-CMDGGOBGSA-N (e)-dec-2-en-1-ol Chemical compound CCCCCCC\C=C\CO QOPYYRPCXHTOQZ-CMDGGOBGSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- MXNRLFUSFKVQSK-UHFFFAOYSA-N 2-Amino-6-(trimethylazaniumyl)hexanoate Chemical compound C[N+](C)(C)CCCCC(N)C([O-])=O MXNRLFUSFKVQSK-UHFFFAOYSA-N 0.000 description 1
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- KKAJSJJFBSOMGS-UHFFFAOYSA-N 3,6-diamino-10-methylacridinium chloride Chemical compound [Cl-].C1=C(N)C=C2[N+](C)=C(C=C(N)C=C3)C3=CC2=C1 KKAJSJJFBSOMGS-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- CQSRUKJFZKVYCY-UHFFFAOYSA-N 5alpha-isofucostan-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=CC)C(C)C)C1(C)CC2 CQSRUKJFZKVYCY-UHFFFAOYSA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000020154 Acnes Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000000884 Airway Obstruction Diseases 0.000 description 1
- 241000199899 Alariaceae Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- BRYYLWHNGJJMQM-UHFFFAOYSA-N Anonaine Natural products C1OC2=CC3=CCNC4=C3C(=C2O1)C5=CC=CCC5C4 BRYYLWHNGJJMQM-UHFFFAOYSA-N 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 241000169680 Aphloia theiformis Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- DPQCZNIGGNJGTD-UHFFFAOYSA-N Chloride-(??)-2-Methylpentanoic acid Natural products CCCCCCC=CCCCCCCCCCC(=O)OC(C)C(C)OC(=O)CCCCCCCC=CCCCCCC DPQCZNIGGNJGTD-UHFFFAOYSA-N 0.000 description 1
- 206010008589 Choking Diseases 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- DPQCZNIGGNJGTD-MVCBGFDASA-N Coixenolide Chemical compound CCCCCC\C=C\CCCCCCCCCC(=O)O[C@@H](C)[C@@H](C)OC(=O)CCCCCCC\C=C/CCCCCC DPQCZNIGGNJGTD-MVCBGFDASA-N 0.000 description 1
- 244000160089 Crataegus cuneata Species 0.000 description 1
- 235000008440 Crataegus cuneata Nutrition 0.000 description 1
- 235000017159 Crataegus pinnatifida Nutrition 0.000 description 1
- 235000014283 Crataegus pinnatifida var major Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- BOKVLBSSPUTWLV-UHFFFAOYSA-N D-N-Methyl coclaurine Natural products C1=2C=C(O)C(OC)=CC=2CCN(C)C1CC1=CC=C(O)C=C1 BOKVLBSSPUTWLV-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000946389 Ecklonia kurome Species 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 206010014733 Endometrial cancer Diseases 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- GBBBJSKVBYJMBG-QTWVXCTBSA-N Fucosterol Natural products CC=C(CC[C@@H](C)[C@@H]1CC[C@@H]2[C@H]3C=C[C@@H]4C[C@H](O)CC[C@@]4(C)[C@@H]3CC[C@@]12C)C(C)C GBBBJSKVBYJMBG-QTWVXCTBSA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- FEUWBELGELLWPV-UHFFFAOYSA-N Glycerol sinapate Natural products COC1=C(O)C(OC)=CC(C=CC(=O)OCC(COC(=O)C=CC=2C=C(OC)C(O)=C(OC)C=2)OC(=O)C=CC=2C=C(OC)C(O)=C(OC)C=2)=C1 FEUWBELGELLWPV-UHFFFAOYSA-N 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 229940122355 Insulin sensitizer Drugs 0.000 description 1
- 206010067997 Iodine deficiency Diseases 0.000 description 1
- OSELKOCHBMDKEJ-VRUYXKNBSA-N Isofucosterol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@@H]2[C@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C OSELKOCHBMDKEJ-VRUYXKNBSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- CMUNUTVVOOHQPW-LURJTMIESA-N L-proline betaine Chemical compound C[N+]1(C)CCC[C@H]1C([O-])=O CMUNUTVVOOHQPW-LURJTMIESA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241001466452 Laminariaceae Species 0.000 description 1
- 229920001543 Laminarin Polymers 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- OBIOZWXPDBWYHB-UHFFFAOYSA-N Nobiletin Natural products C1=CC(OC)=CC=C1C1=C(OC)C(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 OBIOZWXPDBWYHB-UHFFFAOYSA-N 0.000 description 1
- 241000209477 Nymphaeaceae Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 240000001090 Papaver somniferum Species 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- NLAWPKPYBMEWIR-VGQRFNKBSA-N Poncirin Natural products O([C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1Oc1cc(O)c2C(=O)C[C@@H](c3ccc(OC)cc3)Oc2c1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 NLAWPKPYBMEWIR-VGQRFNKBSA-N 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 235000015533 Prunus davidiana Nutrition 0.000 description 1
- 240000002381 Prunus davidiana Species 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 241000015177 Saccharina japonica Species 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- CUXYLFPMQMFGPL-SUTYWZMXSA-N all-trans-octadeca-9,11,13-trienoic acid Chemical compound CCCC\C=C\C=C\C=C\CCCCCCCC(O)=O CUXYLFPMQMFGPL-SUTYWZMXSA-N 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- UZFLPKAIBPNNCA-BQYQJAHWSA-N alpha-ionone Chemical compound CC(=O)\C=C\C1C(C)=CCCC1(C)C UZFLPKAIBPNNCA-BQYQJAHWSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- IJTNSXPMYKJZPR-WVRBZULHSA-N alpha-parinaric acid Natural products CCC=C/C=C/C=C/C=CCCCCCCCC(=O)O IJTNSXPMYKJZPR-WVRBZULHSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- VNEMVKOXLBIWTB-UHFFFAOYSA-N aminomethyl benzoate Chemical group NCOC(=O)C1=CC=CC=C1 VNEMVKOXLBIWTB-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002686 anti-diuretic effect Effects 0.000 description 1
- 230000002927 anti-mitotic effect Effects 0.000 description 1
- 230000002513 anti-ovulatory effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- GKIRPKYJQBWNGO-OCEACIFDSA-N clomifene Chemical compound C1=CC(OCCN(CC)CC)=CC=C1C(\C=1C=CC=CC=1)=C(\Cl)C1=CC=CC=C1 GKIRPKYJQBWNGO-OCEACIFDSA-N 0.000 description 1
- 229960003608 clomifene Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- FBSAITBEAPNWJG-UHFFFAOYSA-N dimethyl phthalate Natural products CC(=O)OC1=CC=CC=C1OC(C)=O FBSAITBEAPNWJG-UHFFFAOYSA-N 0.000 description 1
- 229960001826 dimethylphthalate Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- QOLIPNRNLBQTAU-UHFFFAOYSA-N flavan Chemical compound C1CC2=CC=CC=C2OC1C1=CC=CC=C1 QOLIPNRNLBQTAU-UHFFFAOYSA-N 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- OSELKOCHBMDKEJ-JUGJNGJRSA-N fucosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC\C(=C/C)C(C)C)[C@@]1(C)CC2 OSELKOCHBMDKEJ-JUGJNGJRSA-N 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 235000006479 iodine deficiency Nutrition 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- DBTMGCOVALSLOR-VPNXCSTESA-N laminarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](O)C(O[C@H]2[C@@H]([C@@H](CO)OC(O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-VPNXCSTESA-N 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- HPJKCIUCZWXJDR-UHFFFAOYSA-N letrozole Chemical compound C1=CC(C#N)=CC=C1C(N1N=CN=C1)C1=CC=C(C#N)C=C1 HPJKCIUCZWXJDR-UHFFFAOYSA-N 0.000 description 1
- 229960003881 letrozole Drugs 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- USOSNFWVEWONDB-UHFFFAOYSA-N liriodendrin Natural products COc1cc(cc(OC)c1OC2OC(CO)C(O)C(O)C2O)C3OC(C)(C)C4C(OC(C)(C)C34)c5cc(OC)c(OC6OC(CO)C(O)C(O)C6O)c(OC)c5 USOSNFWVEWONDB-UHFFFAOYSA-N 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- MRIAQLRQZPPODS-UHFFFAOYSA-N nobiletin Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 MRIAQLRQZPPODS-UHFFFAOYSA-N 0.000 description 1
- 239000000242 nostrum Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940127234 oral contraceptive Drugs 0.000 description 1
- 239000003539 oral contraceptive agent Substances 0.000 description 1
- 229940100688 oral solution Drugs 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 235000006502 papoula Nutrition 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000013930 proline Nutrition 0.000 description 1
- 229930001545 pronuciferine Natural products 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229960004586 rosiglitazone Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- CMUNUTVVOOHQPW-ZCFIWIBFSA-N stachydrine Natural products C[N+]1(C)CCC[C@@H]1C([O-])=O CMUNUTVVOOHQPW-ZCFIWIBFSA-N 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000003699 striated muscle Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- LVBXEMGDVWVTGY-UHFFFAOYSA-N trans-2-octenal Natural products CCCCCC=CC=O LVBXEMGDVWVTGY-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- GXPHKUHSUJUWKP-UHFFFAOYSA-N troglitazone Chemical compound C1CC=2C(C)=C(O)C(C)=C(C)C=2OC1(C)COC(C=C1)=CC=C1CC1SC(=O)NC1=O GXPHKUHSUJUWKP-UHFFFAOYSA-N 0.000 description 1
- 229960001641 troglitazone Drugs 0.000 description 1
- GXPHKUHSUJUWKP-NTKDMRAZSA-N troglitazone Natural products C([C@@]1(OC=2C(C)=C(C(=C(C)C=2CC1)O)C)C)OC(C=C1)=CC=C1C[C@H]1SC(=O)NC1=O GXPHKUHSUJUWKP-NTKDMRAZSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/60—Edible seaweed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Chinese medicinal formulaes for the conditioning of intermingled phlegm and blood stasis type Stein-Leventhal syndrome, are related to the field of Chinese medicines.It containing the bulk pharmaceutical chemicals that following weight matches by being prepared: 10-20 parts of Exocarpium Citri Grandis, 6-15 parts of peony, 6-15 parts of peach kernel, 10-30 parts of raw hawthorn, 10-30 parts of Semen Coicis Semen Coicis, 6-15 parts of perillaseed, 10-20 parts of radish seed, 10-30 parts of thallus laminariae, 10-20 parts of endothelium corneum gigeriae galli, 10-30 parts of lotus leaf.The effect of prescription of the present invention has strengthening the spleen and reducing phlegm, and disappear rouge dissipating bind, blood circulation, suitable for the treatment and maintenance of intermingled phlegm and blood stasis type Stein-Leventhal syndrome, Chinese medicine prescription passes through scientific composition, and verifies curative effect through the clinical use of experimental study and many years.It, which levies the polycystic ovary for belonging to phlegm and blood stasis, good curative effect, can effectively improve the clinical symptoms that card belongs to the polycystic ovary sign patient of phlegm and blood stasis.And mouthfeel is suitable for, flavour of a drug safety is suitble to exploitation to take for a long time to raise class Chinese medicinal food.
Description
Technical field
The present invention relates to the field of Chinese medicines, for a kind of Chinese medicinal formulae for the conditioning of intermingled phlegm and blood stasis type Stein-Leventhal syndrome.
Background technique
Stein-Leventhal syndrome (polycystic ovary syndrome, PCOS) is a kind of morbidity multi-cause, clinical table
Existing polymorphism, the endocrinic syndrome characterized by long-term No-clay weak interbed and hyperandrogenism.It is common for clinical gynecological endocrine
Disease, have huge patient population in China.PCOS clinical manifestation is heterogeneous, not only seriously affects the reproductive function of patient,
And estrogen-dependent tumor such as onset of endometrial cancer rate increases, and relevant metabolism disorder includes hyperandrogenism, pancreas
Insulin resistance, abnormal carbohydrate metabolism, Anomalous lipid metablism, cardiovascular disease risk also increase.Foreign countries report PCOS accounts for childbearing age woman
Woman 5%~10%, accounts for the 30%~60% of anovulatory infertility patient.
Stein-Leventhal syndrome (PCOS) is mainly the relationship due to hormone secretion amount between hypothalamus, hypophysis, ovary
It is abnormal, cause oligomenorrhea, amenorrhoea, irregular vagina bleeding, crinosity, obesity, infertile, the concurrent more cystis degenerations of bilateral ovaries increase
Etc. a series of syndromes.Clinic is especially common with amenorrhoea caused by Stein-Leventhal syndrome, infertility and is difficult to cure.It there is no at present
Ideal treatment method, requirement generally according to the type of symptom, severity and the age of patient, and to fertility select
Treatment method.The class of medications of PCOS doctor trained in Western medicine is mainly at present: 1, reducing the drug therapy of hyperandrogenism, mainly make
With oral contraceptive, hormone medicine;2, promoting ovulation drug is treated, predominantly Clomifene, promoting sexual gland hormone (Gn) and Letrozole
Deng;3, insulin sensitizer (ISD) is treated, and mainly has melbine, troglitazone, Rosiglitazone etc..But these treatment means
(drug) can not solve all diseases of PCOS because of its different side effect simultaneously for the PCOS patient for having fertility to require
Shape, but need to settle one by one to greatly increase treatment difficulty.And for traditional Chinese medicine, it is directed to by compound compatibility
Property conditioning, then can be treated simultaneously for all problems of PCOS, and there is no the side effect of hormone bring.
The clinical symptoms of Stein-Leventhal syndrome are found in Chinese medicine " amenorrhoea ", " wrong after menstruation ", " infertile ", " metrorrhagia and metrostaxis ", " moon
Through lacking of proper care " etc. illnesss scope, its rear caused amenorrhoea, infertility are especially common, and are difficult to cure, and need to verify conditioning for a long time.
And the disease Chinese medical discrimination, and multiple syndromic types can be divided into.Inventors believe that phlegm and blood stasis is one of main pathogenesis of this disease,
Thus intermingled phlegm and blood stasis type is one of those important syndromic types of this disease.The primary symptom of the type shows themselves in that oligomenorrhea, amenorrhoea, shape
Body is plentiful or fat, acne, and crinosity is infertile, habitual abortion, bulimia, and abdominal distension is out of strength, abundant expectoration, the tired limb weight of mind, drowsiness,
Inhibited defecation, slippery or heavy cunning.Clinic is more common in insulin resistance, hyperandrogenism person.
The prescription of this invention, which empirically sums up for inventor from many years gynecological clinic, carrys out intermingled phlegm and blood stasis type polycystic ovary
The core prescription of syndrome conditioning, for many years clinic plus-minus variation based on this side are comprehensive for intermingled phlegm and blood stasis type polycystic ovary
The conditioning of sign obtains good result.The medicinal material content range that the claims in the present invention are advocated is specifically in patent medicine and food
Product exploitation and the recipe quantity designed, prescription medicine usage amount constitute situation of change from not publicly leaking, the group of prescription of the present invention
All very rationally, use is safe for refining for side and dosage, is particularly suitable for exploitation at comprehensive for intermingled phlegm and blood stasis type polycystic ovary
The Chinese medicine nostrum and relevant food of the conditioning of sign.
Summary of the invention
This invention inventor summarizes many years of experience, provides one kind and is specifically applied to intermingled phlegm and blood stasis type polycystic ovary synthesis
Requisition reason Chinese medicinal formulae, have it is curative for effect, refining formula safety, tolerance is good, and because conditioning must Long-term taking medicine due to make a special trip to a certain place
Be directed to fire derived from stagnation of liver-QI type Women of childbearing age mouthfeel carry out prescription design to enhance the compliance that it is taken, be suitble to new Chinese medicine and
The characteristics of food development.
The technical solution adopted by the present invention is that:
A kind of Chinese medicinal formulae for the conditioning of intermingled phlegm and blood stasis type Stein-Leventhal syndrome.It is characterized in that by the Chinese medicine of following parts by weight
It is made:
10-20 parts of Exocarpium Citri Grandis, 6-15 parts of peony, 6-15 parts of peach kernel, 10-30 parts of raw hawthorn, 10-30 parts of Semen Coicis Semen Coicis, perillaseed
6-15 parts, 10-20 parts of radish seed, 10-30 parts of thallus laminariae, 10-20 parts of endothelium corneum gigeriae galli, 10-30 parts of lotus leaf.
As preference:
The Chinese medicine material parts by weight constitute as follows: 12-18 parts of Exocarpium Citri Grandis, 9-12 parts of peony, and 9-12 parts of peach kernel, raw hawthorn
15-24 parts, 15-24 parts of Semen Coicis Semen Coicis, 9-12 parts of perillaseed, 12-18 parts of radish seed, 15-24 parts of thallus laminariae, 12-18 parts of endothelium corneum gigeriae galli, lotus
15-24 parts of leaf.
The further preferably described Chinese medicine material parts by weight are constituted are as follows: and 15 parts of Exocarpium Citri Grandis, 10 parts of peony, 10 parts of peach kernel, raw hawthorn
20 parts, 20 parts of Semen Coicis Semen Coicis, 10 parts of perillaseed, 15 parts of radish seed, 20 parts of thallus laminariae, 15 parts of endothelium corneum gigeriae galli, 20 parts of lotus leaf.
The major function of Chinese medicinal formulae of the present invention are as follows: strengthening the spleen and reducing phlegm, disappear rouge dissipating bind, blood circulation.It is mutual for phlegm-blood stasis
Wrong, Stein-Leventhal syndrome after amenorrhoea, menstruation caused by knot.Its prescription side solution is the mechanism of action are as follows:
We are erchen tang, sanzi yangqin decoction, Taohong Siwu Tangization sanction.Exocarpium Citri Grandis strengthening the spleen and replenishing qi, dispelling phlegm and eliminating dampness, peach in side
Benevolence dissipating blood stasis with potent drugs promoting menstruation, sets for main pathogenesis, therefore is altogether monarch drug in a prescription.Raw hawthorn activating microcirculation and removing stasis medicinal, modern pharmacology show there is lipid-loweringing
Effect;Semen coicis invigorating spleen to remove dampness, perillaseed, radish seed regulating qi-flowing for eliminating phlegm, meet Chinese medicine " control phlegm and first control gas, phlegm rising following QI and rise, with gas
Drop and drop " it is theoretical;Above-mentioned four medicine is ministerial drug altogether.Peony promoting blood circulation for regulating menstruation, lotus leaf dampness removing lipid-loweringing, thallus laminariae dissolving phlegm resolving hard lump, chicken
Interior gold food digesting stomach fortifying, above-mentioned four medicine is adjuvant altogether.All medicines share plays strengthening the spleen and reducing phlegm altogether, and disappear rouge dissipating bind, the function of blood circulation.
The pharmacological action of each compatibility Chinese medicine is described below in prescription:
Exocarpium Citri Grandis: for rutaceae Citrus grandis Citrus grandis Tomentosa or shaddock Citrus grandis (L.)
The prematurity of Osbeck or maturescent dry outside rind.Acrid flavour, hardship, it is warm-natured.Return lung, the spleen channel.With cold dispelling, eliminating dampness, benefit
Gas, the function of dissolving phlegm.For cough due to wind-cold evil, larynx is itched abundant expectoration, and dyspepsia is got sick from drinking too much wine, and evil of vomitting ruffian is bored.Containing volatile oil, principal component is lemon
Aldehyde, Geraniol, linalool, adjacent amino Methyl Benzoate, limonene, a- firpene etc..Flavones ingredient: naringin, new orange peel
Glucoside, Poncirin, tangerine produced in fujian province element, Nobiletin, 5,7,4'-trimethoxyflavone etc.;Stachydrine, umbelliferone, orange oil lactone,
Glycine, Sitosterolum glycoside, nonacosane etc..Contain protein again, fatty, carbohydrate, carrotene, vitamin B1, B2, C,
Niacin etc..Modern study proves that there is the effects of anti-inflammatory, to reduce blood viscosity, promote blood circulation.
Peony: for the flower of ranunculaceae peony.It is bitter, light, it is mild-natured.With regulating menstruation and activating blood, the function of removing blood stasis and acesodyne.
Clinic cures mainly menoxenia, the diseases such as dysmenorrhea.Its main component has volatile oil, protein, fatty acid, flavones, pattern
Element, flavonols etc. and the elements such as K, Ca, Mg, P, Se and VB1, VB2 and carotenoid etc..There is promoting blood circulation, removing blood stasis and relieving pain effect.
Peach kernel: for rosaceous plant peach Prunus persica(L.) Batsch or mountain peach Prunus davidiana
(Carr.) dry mature seed of Franch..Sweet-bitter flavor, it is mild-natured.Enter the heart, liver.Large intestine channel.With promoting blood circulation, relax bowel and defecation
The effect of.It is clinically used for menostasis, dysmenorrhea , wei lump in the abdomen lump in the abdomen, injury from falling down, dry constipation of intestines etc..Modern study its contain peach kernel containing hardship
Almond glucoside, volatile oil, fat oil, glucose, protein, sucrose etc.;It is main in oil to contain olein and a small amount of linoleic acid
Ester.Separately containing emulsin etc..Pharmacology confirmation has the effects that expand blood vessel, reduces blood viscosity, anti-inflammatory, antiallergy.
Hawthorn: for rosaceous plant large-fruited Chinese hawthorn Crataegus pinnatifida Bge.var.major N.E.Br. or
The dry mature fruit of hawthorn Crataegus pinnatifida Bge., the core for removing impurity and falling off.Acrid flavour, sweet, property is micro-
Temperature.Enter spleen, stomach, Liver Channel.With food digesting stomach fortifying, the effect of scattered stasis.It is clinically used for meat stagnation, gastral cavilty turgor, dysentery abdomen
Bitterly, blood stasis closed, postpartum stasis, confidant sting, hernia pain;Hyperlipidemia etc..Modern study principle active component is flavones
Constituents and triterpenes components have left-handed youngster's table caffein, Quercetin, hyperin, ursolic acid, chlorogenic acid, citric acid, citric acid
Mono-methyl, citron dimethyl phthalate, Trimethyl citrate, flavan polymers etc..Pharmacology confirm have promote digestion, heart tonifying, blood pressure lowering,
Reducing blood lipid, it is anti-oxidant, improve immunity the effects of.
Semen coicis: for gramineae Coix lacryma-jobi L. var. ma-yuen (Roman.)
The dry mature kernal of Stapf.It is sweet in flavor, light, it is cool in nature.Enter spleen, stomach, lung channel.With invigorating the spleen excreting dampness, remove numbness antidiarrheal, heat-clearing row is dense
The effect of.It is clinically used for oedema, tinea pedis, difficult urination, arthritis with fixed pain caused by dampness muscular constricture, splenasthenic diarrhea, pulmonary abscess, acute appendicitis;Verruca plana etc..Modern times grind
Studying carefully main component has protein, fat, carbohydrate, amino acid (for leucine, lysine, arginine, tyrosine etc.), coix lacryma-jobi
Element, Coixenolide, triterpenoid, a small amount of vitamin B1 etc..Pharmacology confirms coix seed oil (predominantly palmitinic acid and its ester) to exhaling
It inhales, it is a small amount of excited, it is a large amount of to benumb (central);Pulmonary Vascular can be made significantly to expand.To isolated frog heart and isolated rabbit intestines, low concentration is in
Excitation, high concentration are in inhibiting effect;To rabbit and cavy uterus generally in excitation, adrenaline can invert its excitement
Effect;There are also antidiuretic activities for it;Can largely animal be made to benumb, have inhibiting effect to striated muscle, there is prevention to grow up in cancer cell
And the effects of injury.
Perilla seed: for the dry mature fruit of Lamiaceae plant purple perilla Perilla frutescens(L.) Britt..Autumn
It is harvested when season fruit maturation, removes impurity, dry.Acrid flavour is warm-natured.It is distributed in lung channel.With sending down abnormally ascending dissolving phlegm, relieving asthma, purging and intestine lubricating action.With
In phlegm stops up the circulation of vital energy in the wrong direction, cough and asthma, dry constipation of intestines.Perillaseed contains the ingredients such as albumen, grease sterol.Wherein grease has fatty acid and Asia
Numb acid, linoleic acid;Lecithin, cephalin and phosphatidyl serine etc..It is mainly cupreol in sterol.Modern study proves that having
The effects of antitumor, raising learning ability and extension spontaneous hypertensive rat time-to-live.
Radish seed: for the dry mature seed of crucifer radish Raphanus sativus L..It is pungent, sweet, it is mild-natured.
Return lung, spleen, stomach meridian.Function help digestion and eliminate flatulence, lowering the adverse-rising QI to resolve phlegm.Fatty oil, volatile oil.There is methyl mercaptan etc. in volatile oil.Fat oil
In erucic acid containing volume, linoleic acid, linolenic acid and glycerol sinapate etc..For retention of food and drink, abdominal distention, constipation,
Stagnation and diarrhea, phlegm choking, dyspnea and cough.
Thallus laminariae: for Laminariaceae plant sea-tangle Laminaria japonica Aresch. or Alariaceae plant kelp (the goose palm
Dish) Ecklonia kurome Okam. drying thallus.Summer, Qiu Erji fish, and dry.Taste is salty, cold in nature.Return liver, stomach, kidney
Through.With resolving hard lump, dissolving phlegm, the function of sharp water.For goiter, scrofula, testiclar gall, phlegm retention oedema.Rich in polysaccharide component
Phycocolloid acid and laminaran, mannitol, inorganic salts, vitamin C, protein, volatile oil and amino acid and it is micro contain carrotene, core
Flavine etc..Aminoacid ingredient: laminine, glutamic acid, aspartic acid, proline, alanine, group ammonia, tryptophan, methionine
Deng.Also contain sweet dew, taurine, eicosapentaenoic acid, brown eleostearic acid, oleic acid, linoleic acid, gamma-Linolenic acid, parinaric acid, flower
Raw tetraenoic acid, fucosterol etc..Separately contain volatile oil, includes principal component: cubeb oil enol, hexanal, (E) -2- hexenoic aldehyde, (E) -
2- hexenol, hexanol, dimethylbenzene, 1-OCOL, (E, E) -2,4- heptadienal, butyl, (E) -2- octenal, (E) -2-
Matsutake alcohol, (E, E) -2,4- zinn diene aldehyde, (E, Z) -2,6- nonadienal, (E) -2- nonenyl aldehyde, alpha-terpineol, β-ring lemon
The high cyclocitral of aldehyde, β -, (E) -2- decenol, (E, E) -2,4- decadienal, alpha, beta-lonone, pentadecane, table cubeb oil
Enol and myristic acid, ω-gaidic acid, pohytol etc..Thallus laminariae can be used to correct the thyroid gland machine as caused by iodine deficiency
Can be insufficient, while can also temporarily inhibit the metabolic rate of hyperthyroidism and mitigate symptom.There are also drop for pharmacological action
Pressure, hypoglycemic, it is anticoagulant, anti-radiation the effects of.
Endothelium corneum gigeriae galli: for the drying inner wall of sandbag of Phasianidae animal family chicken Gallus gallus domesticus Brisson.
It is sweet in flavor, it is mild-natured.Enter spleen, stomach, small intestine, bladder meridian.It has stomach invigorating and digestion promoting effects, the effect of arresting seminal emission.It is clinically used for dyspepsia, is vomitted
Vomiting and diarrhoea dysentery, infantile malnutrition, the enuresis, spermatorrhea etc..Main component has gastric hormone, keratin, a variety of amino acid pepsins, starch
Enzyme, multivitamin and microelement etc..Pharmacology, which confirms to have, promotes gastric secretion, acidity and eupepsy, promotes peristole
The effects of.
Lotus leaf: for the dried leaf of nymphaeaceae plant lotus Nelumbo nucifera Gaertn..It summer, the harvesting of two season of autumn, shines
When doing to seven, eighty per cant, petiole is removed, is converted into semicircle or folding fan-shaped, it is dry.Bitter is mild-natured, returns liver, spleen, stomach meridian.With heat-clearing
Relieving summer-heat, sending up the lucid yang, the function of cooling blood and hemostasis.For hot summer weather polydipsia, summer heat damp diarrhea, splenasthenic diarrhea, blood-head tells nosebleed, uterine bleeding of having blood in stool.
Burnt FOLIUM NELUMBINIS inducing astrigency removing blood stasis and hemostasis.For a variety of haemorrhages and postpartum anemic fainting.Leaf is containing nuciferine, Nuciferine, miltanthin, sub- U.S. opium poppy
Alkali, Pronuciferine, N- demethyl Nuciferine, D-N- methyl coclaurine, anonaine, liriodendrin, Quercetin, Isoquercitrin,
Lotus glucoside, tartaric acid, citric acid, malic acid, gluconic acid, oxalic acid, succinic acid, tannin.The also alkalinity of the effect containing antimitotic
Ingredient.
Clinical research
Clinical verification and 36 intermingled phlegm and blood stasis type patients with polycystic ovary syndrome of the Chinese medicinal formulae of the present invention through many years are faced
Bed verifying, it is as a treatment course with three months, it the use of present invention side is basic square into conditioning.After one course for the treatment of, the more capsules of intermingled phlegm and blood stasis type
Ovary Syndrome improves the dilute hair of patient menstrual, and acne, bulimia, abdominal distension is out of strength, abundant expectoration, and the tired limb weight of mind, drowsiness, stool is not
The symptoms such as smooth improve efficient up to 100%.Continue using after conditioning 1 year, successfully pregnancy person is up to 63.89%.It is all to take our trouble
Person is showed no adverse reaction.
Oligomenorrhea, amenorrhoea, body is plentiful or fat, acne, and crinosity is infertile, habitual abortion, bulimia, abdominal distension,
Out of strength, abundant expectoration, the tired limb weight of mind, drowsiness, inhibited defecation slippery or heavy slides.Clinic is more common in insulin resistance, hyperandrogenism
Person.Typical clinical case
Case 1
Huang, female are 30 years old, married.In September, 2011 first visit in * days.Main suit: oligomenorrhea more than 5 years, 7 years unpregnancies after marriage.Existing disease
History: amenorrhoea 6 months, fat, crinosity, bulimia, abdominal distension is out of strength, abundant expectoration, the tired limb weight of mind, drowsiness, inhibited defecation, slippery, tongue
Dark yellow and greasy fur.B ultrasound shows: left ovary 4cm*3.4cm*2.8cm, right ovary 3.8cm*3.4cm*3.0cm, bilateral ovaries
See that the ovarian follicle of middle 2~9 mm of diameter is multiple.T232ng/ml is shown in sex hormone detection, is higher than normal value.Diagnosis: polycystic ovary is comprehensive
It levies (intermingled phlegm and blood stasis type).It is basic side's conditioning with prescription of the present invention.After three months, bulimia, abdominal distension is out of strength, abundant expectoration, and mind is tired
Limb weight, drowsiness, inhibited defecation disappears, and face acnes substantially mitigate, continuous to take March, and acne recovery from illness, androgen levels restore normal,
It is smoothly pregnant after following the service 6 months.
Case 2
What certain, female is 27 years old, married.* days in March, 2013 of first visit.Main suit: it miscarries 4 times in oligomenorrhea more than 4 years, once 2 years, most
Nearly 3 years post-abortions unpregnancy.Present illness history: not secondary menstruation is before 45 days, and body is plentiful, and acne, crinosity is hyperfunction, and abdominal distension is out of strength,
Abundant expectoration, the tired limb weight of mind, drowsiness, inhibited defecation, deeptensepulse is sliding, and the greasy western medicine treatment effect of the red tongue fur of tongue is bad, seeks Chinese traditional treatment.B ultrasound
Show: right ovary 3.8cm*3.5cm*3.1cm, it is seen that the ovarian follicle of middle 2~9 mm of diameter is multiple.Endocrinological inspection measures
T229ng/ml is higher than normal value, insulin resistance.Diagnosis: Stein-Leventhal syndrome (intermingled phlegm and blood stasis type).With prescription of the present invention
For basic side's conditioning.After 6 months, all diseases be totally disappeared, androgen levels restore normal, is smoothly pregnant after following the service 8 months.2015 2
Month, it cuts open and produces a girl baby, mother and daughter's health.
Conditioning of the prescription of the present invention to intermingled phlegm and blood stasis type patients with polycystic ovary syndrome in summary, safely and effectively,
Exploitation is very suitable into Chinese materia medica preparation.In addition prescription of the present invention is integration of drinking and medicinal herbs class medicinal material, takes safety, and mouthfeel is suitable for suffering from
The tolerance that person uses it is more preferable compared with other medicines nor it is normally opened hair at conditioning-type Chinese medicine based food.
Specific embodiment
The present invention is further illustrated with reference to embodiments.
Embodiment 1
Weigh 15 parts of Exocarpium Citri Grandis, 10 parts of peony, 10 parts of peach kernel, 20 parts of raw hawthorn, 20 parts of Semen Coicis Semen Coicis, 10 parts of perillaseed, radish
15 parts, 20 parts of thallus laminariae, 15 parts of endothelium corneum gigeriae galli, 20 parts of lotus leaf of son.
Preparation step:
By the weighed each taste Chinese medicine of institute, decoction is decocted by traditional handicraft or Chinese patent medicine preparation technique routinely is processed into middle traditional Chinese medicines
The clinical main Chinese patent medicine preparation such as tablet defined in allusion quotation, pill, capsule, granule, powder or oral solution or according to routine
Food is made in food processing technology.
Embodiment 2
Weigh 10 parts of Exocarpium Citri Grandis, 15 parts of peony, 6 parts of peach kernel, 30 parts of raw hawthorn, 10 parts of Semen Coicis Semen Coicis, 15 parts of perillaseed, radish seed
10 parts, 30 parts of thallus laminariae, 10 parts of endothelium corneum gigeriae galli, 30 parts of lotus leaf.
Preparation step is the same as embodiment 1.
Embodiment 3
Weigh 20 parts of Exocarpium Citri Grandis, 6 parts of peony, 15 parts of peach kernel, 10 parts of raw hawthorn, 30 parts of Semen Coicis Semen Coicis, 6 parts of perillaseed, radish seed
20 parts, 10 parts of thallus laminariae, 20 parts of endothelium corneum gigeriae galli, 10 parts of lotus leaf.
Preparation step is the same as embodiment 1.
Embodiment 4
Weigh 12 parts of Exocarpium Citri Grandis, 12 parts of peony, 9 parts of peach kernel, 24 parts of raw hawthorn, 15 parts of Semen Coicis Semen Coicis, 12 parts of perillaseed, radish seed
18 parts, 24 parts of thallus laminariae, 12 parts of endothelium corneum gigeriae galli, 15 parts of lotus leaf.
Preparation step is the same as embodiment 1.
Embodiment 5
Weigh 18 parts of Exocarpium Citri Grandis, 9 parts of peony, 12 parts of peach kernel, 15 parts of raw hawthorn, 24 parts of Semen Coicis Semen Coicis, 9 parts of perillaseed, radish seed
12 parts, 15 parts of thallus laminariae, 18 parts of endothelium corneum gigeriae galli, 24 parts of lotus leaf.
Preparation step is the same as embodiment 1.
Embodiment 6
Weigh 12 parts of Exocarpium Citri Grandis, 10 parts of peony, 12 parts of peach kernel, 18 parts of raw hawthorn, 18 parts of Semen Coicis Semen Coicis, 10 parts of perillaseed, radish
18 parts, 18 parts of thallus laminariae, 18 parts of endothelium corneum gigeriae galli, 18 parts of lotus leaf of son.
Preparation step is the same as embodiment 1.
Embodiment 7
Weigh 18 parts of Exocarpium Citri Grandis, 9 parts of peony, 10 parts of peach kernel, 20 parts of raw hawthorn, 15 parts of Semen Coicis Semen Coicis, 10 parts of perillaseed, radish seed
15 parts, 15 parts of thallus laminariae, 12 parts of endothelium corneum gigeriae galli, 20 parts of lotus leaf.
Preparation step is the same as embodiment 1.
Embodiment 8
Weigh 15 parts of Exocarpium Citri Grandis, 9 parts of peony, 12 parts of peach kernel, 24 parts of raw hawthorn, 18 parts of Semen Coicis Semen Coicis, 9 parts of perillaseed, radish seed
12 parts, 18 parts of thallus laminariae, 15 parts of endothelium corneum gigeriae galli, 24 parts of lotus leaf.
Preparation step is the same as embodiment 1.
Embodiment 9
Weigh 12 parts of Exocarpium Citri Grandis, 12 parts of peony, 10 parts of peach kernel, 15 parts of raw hawthorn, 15 parts of Semen Coicis Semen Coicis, 9 parts of perillaseed, radish seed
18 parts, 18 parts of thallus laminariae, 18 parts of endothelium corneum gigeriae galli, 18 parts of lotus leaf.
Preparation step is the same as embodiment 1.
Above content is only how implementing example explanation to the present invention, rather than protection scope of the present invention, institute
Belong to various modifications or supplement that those skilled in the art do described specific embodiment or by a similar method
Substitution, structure without departing from invention or beyond the scope defined by this claim should belong to protection of the invention
Range.
Claims (4)
1. a kind of Chinese medicinal formulae for the conditioning of intermingled phlegm and blood stasis type Stein-Leventhal syndrome, it is characterized in that by following parts by weight
Medicine is made:
10-20 parts of Exocarpium Citri Grandis, 6-15 parts of peony, 6-15 parts of peach kernel, 10-30 parts of raw hawthorn, 10-30 parts of Semen Coicis Semen Coicis, perillaseed
6-15 parts, 10-20 parts of radish seed, 10-30 parts of thallus laminariae, 10-20 parts of endothelium corneum gigeriae galli, 10-30 parts of lotus leaf.
2. the Chinese medicinal formulae according to claim 1 for the conditioning of intermingled phlegm and blood stasis type Stein-Leventhal syndrome, it is characterized in that
It is prepared from the following traditional Chinese medicines in parts by weight:
12-18 parts of Exocarpium Citri Grandis, 9-12 parts of peony, 9-12 parts of peach kernel, 15-24 parts of raw hawthorn, 15-24 parts of Semen Coicis Semen Coicis, perillaseed
9-12 parts, 12-18 parts of radish seed, 15-24 parts of thallus laminariae, 12-18 parts of endothelium corneum gigeriae galli, 15-24 parts of lotus leaf.
3. the Chinese medicinal formulae according to claim 1 for the conditioning of intermingled phlegm and blood stasis type Stein-Leventhal syndrome, it is characterized in that
It is prepared from the following traditional Chinese medicines in parts by weight:
15 parts of Exocarpium Citri Grandis, 10 parts of peony, 10 parts of peach kernel, 20 parts of raw hawthorn, 20 parts of Semen Coicis Semen Coicis, 10 parts of perillaseed, radish seed 15
Part, 20 parts of thallus laminariae, 15 parts of endothelium corneum gigeriae galli, 20 parts of lotus leaf.
4. the Chinese medicinal formulae according to claim 1 to 3 for the conditioning of intermingled phlegm and blood stasis type Stein-Leventhal syndrome is for making
Application in standby drug and food primary formulation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710744986 | 2017-08-25 | ||
CN2017107449867 | 2017-08-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109420078A true CN109420078A (en) | 2019-03-05 |
Family
ID=65514570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810968222.0A Pending CN109420078A (en) | 2017-08-25 | 2018-08-23 | A kind of Chinese medicinal formulae for the conditioning of intermingled phlegm and blood stasis type Stein-Leventhal syndrome |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109420078A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104474379A (en) * | 2014-12-30 | 2015-04-01 | 兰州古驰生物科技有限公司 | Traditional Chinese medicine preparation with function of eliminating gynecological mass |
-
2018
- 2018-08-23 CN CN201810968222.0A patent/CN109420078A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104474379A (en) * | 2014-12-30 | 2015-04-01 | 兰州古驰生物科技有限公司 | Traditional Chinese medicine preparation with function of eliminating gynecological mass |
Non-Patent Citations (2)
Title |
---|
即问即答: "《家庭医生在线》", 18 November 2015 * |
王玉霞等: "姜坤治疗***经验", 《中医药学报》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102742691A (en) | Health-care tea drink with blood pressure lowering effect and preparation method thereof | |
CN104383132B (en) | Traditional Chinese medicine preparation used for treating gastric ulcer and preparation method | |
CN107019186A (en) | A kind of dietary supplement containing Bee Pollen | |
EP3653219A1 (en) | Composition for treating fatty liver | |
CN104958646A (en) | Chinese medicinal preparation for relaxing bowels and preparation method thereof | |
CN106994141B (en) | Traditional Chinese medicine composition for treating constipation and preparation method thereof | |
CN111919982A (en) | Natural plant beverage for relieving alcoholism and preparation method thereof | |
CN104189472A (en) | Traditional Chinese medicine composition for treating primary hypotension | |
CN109420089A (en) | A kind of Chinese medicinal formulae for improving and preventing for the proliferation of mammary gland | |
CN109420078A (en) | A kind of Chinese medicinal formulae for the conditioning of intermingled phlegm and blood stasis type Stein-Leventhal syndrome | |
CN108324920B (en) | Traditional Chinese medicine composition for treating constipation and preparation method thereof | |
CN105147956A (en) | Traditional Chinese medicine for treating acute peptic ulcer bleeding and preparation method of traditional Chinese medicine | |
CN111419946A (en) | Medicine for treating infertility and preparation method thereof | |
CN109420087A (en) | A kind of Chinese medicinal formulae for the conditioning of fire derived from stagnation of liver-QI type Stein-Leventhal syndrome | |
CN104173812A (en) | Pharmaceutical composition for treating blood-heat bleeding type acute idiopathic thrombocytopenic purpura and preparation method of pharmaceutical composition | |
CN103877513A (en) | Chinese herbal compound composition with blood fat reduction effect, and applications thereof | |
CN117244021B (en) | A Chinese medicinal composition extract for reducing blood sugar, blood lipid, blood pressure and uric acid, and its preparation method | |
CN105125790A (en) | Qi regulating and stomach strengthening preparation for treating gasteremphraxis and preparation method of preparation | |
CN105125693A (en) | Traditional Chinese medicine composition for treating acute gastritis and preparing method thereof | |
CN104784646A (en) | Pharmaceutical composition for treating infantile hernia and preparation method of pharmaceutical composition | |
CN105560627A (en) | Traditional Chinese medicine for treating simple goiter | |
CN104997937B (en) | A kind of blood sugar reducing food containing fructus lycii, health care product or pharmaceutical composition | |
CN105056093A (en) | Medicine for treating chronic gastric and duodenal ulcer and preparing method thereof | |
CN104491537A (en) | Traditional Chinese medicine composition for treating rheumatic heart disease | |
CN104922546A (en) | Traditional Chinese medicine composition curing chronic gastritis and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: Room 803, Yifu scientific research building, Beijing University of traditional Chinese medicine, No. 11, North Third Ring East Road, Chaoyang District, Beijing 100029 Applicant after: Wang Ting Address before: 471002 97-1-201 Xin'an street, Fuhe District, Luoyang City, Henan Province Applicant before: Wang Ting |
|
CB02 | Change of applicant information | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190305 |
|
RJ01 | Rejection of invention patent application after publication |